Liothyronin Orifarm Healthcare

Liothyronine sodium, the active ingredient in Liothyronin Orifarm Healthcare, is a thyroid hormone presented as an oral dosage form for systemic use. It is employed in the management of hypothyroidism and related conditions by replacing deficient triiodothyronine (T3) in patients requiring hormone supplementation.

GNH USA supplies Liothyronin Orifarm Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Liothyronine sodium is used to treat disorders of thyroid hormone deficiency, addressing the underlying metabolic insufficiency. - Hypothyroidism: restores normal thyroid hormone levels and improves metabolic function. - Myxedema: alleviates severe hypothyroid symptoms by providing active T3 hormone. - Thyroid hormone replacement therapy: maintains euthyroid state in patients after thyroidectomy or radioactive iodine treatment.

Adverse reactions to liothyronine sodium may vary in frequency and severity.

Common Side Effects: - Palpitations: sensation of rapid or irregular heartbeat. - Tremor: fine shaking of hands or limbs. - Nervousness: heightened anxiety or irritability. - Heat intolerance: increased sensitivity to warm environments.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening irregular heart rhythm. - Angina pectoris: chest pain due to myocardial ischemia. - Osteoporosis: accelerated bone loss with long‑term excess dosing.

When prescribing liothyronine sodium, clinicians should consider several safety precautions. - Dose adjustment: individualize dose based on age, weight, cardiac status, and thyroid function tests. - Cardiovascular disease: monitor closely in patients with coronary artery disease or arrhythmias. - Diabetes mellitus: watch for altered glucose control due to increased metabolism. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Elderly patients: start with lower doses and titrate cautiously. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Liothyronine sodium can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antithyroid drugs (e.g., methimazole, propylthiouracil): block thyroid hormone action, reducing therapeutic effect. - Beta‑adrenergic antagonists: may mask symptoms of excess thyroid hormone such as tachycardia. - Corticosteroids: increase metabolism of thyroid hormones, potentially lowering serum levels.

Moderate Interactions (Monitor Closely): - Oral contraceptives and estrogen therapy: increase thyroid‑binding globulin, possibly requiring dose adjustment. - Digoxin: enhanced cardiac effects when thyroid hormone levels rise. - Cholesterol‑lowering agents (e.g., cholestyramine): may reduce absorption of liothyronine.